Analystreport

Alnylam Pharmaceuticals (NASDAQ:ALNY) was upgraded by analysts at Freedom Capital from a "hold" rating to a "strong-buy" rating.

Alnylam Pharmaceuticals, Inc.  (ALNY) 
Last alnylam pharmaceuticals, inc. earnings: 2/6 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.alnylam.com/investor-overview